Italy
Tecninox Group, founded in 1979 and headquartered in Italy, is a prominent provider of process solutions for the pharmaceutical and biotech industries. The company specializes in the design, construction, installation, and validation of state-of-the-art equipment tailored for the industry, with a keen focus on integrated automatic control systems.
The company offers comprehensive turnkey solutions for the formulation of pharmaceutical and biotechnological products, including but not limited to vaccines, antibiotics, insulin, and more. With offerings that extend to the production, storage, and distribution of pure fluids, Tecninox Group's facilities adhere to the highest technological standards and regulatory compliances like GEP, ASME, cGMP, GAMP, and FDA.
Despite its robust industry presence, there is no record of recent external investments, suggesting a self-sustained growth strategy. With a fully paid-up share capital of €500,000, Tecninox Group is positioned as a stable yet dynamic player in the pharmaceutical engineering domain. Its strong after-sales service underscores a commitment to client satisfaction by minimizing production downtimes. This combination of innovation and reliability makes Tecninox Group a compelling consideration for venture capital and investors aiming to engage with reputable entities in the pharma-tech sector.
